EWM
ALXN
Edge Wealth Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,095
| Closed | -$482K | – | 455 |
|
|
2020
Q4 | $482K | Buy |
3,095
+188
| +6% | +$29.3K | 0.11% | 68 |
|
|
2020
Q3 | $333K | Sell |
2,907
-250
| -8% | -$28.6K | 0.08% | 83 |
|
|
2020
Q2 | $354K | Hold |
3,157
| – | – | 0.07% | 111 |
|
|
2020
Q1 | $284K | Hold |
3,157
| – | – | 0.06% | 120 |
|
|
2019
Q4 | $341K | Buy |
3,157
+187
| +6% | +$20.2K | 0.07% | 117 |
|
|
2019
Q3 | $290K | Buy |
2,970
+1,562
| +111% | +$153K | 0.07% | 116 |
|
|
2019
Q2 | $182K | Sell |
1,408
-60
| -4% | -$7.76K | 0.04% | 148 |
|
|
2019
Q1 | $199K | Hold |
1,468
| – | – | 0.05% | 134 |
|
|
2018
Q4 | $143K | Sell |
1,468
-555
| -27% | -$54.1K | 0.04% | 157 |
|
|
2018
Q3 | $281K | Sell |
2,023
-315
| -13% | -$43.8K | 0.07% | 118 |
|
|
2018
Q2 | $290K | Buy |
2,338
+400
| +21% | +$49.6K | 0.07% | 119 |
|
|
2018
Q1 | $216K | Sell |
1,938
-4,121
| -68% | -$459K | 0.06% | 119 |
|
|
2017
Q4 | $727K | Sell |
6,059
-630
| -9% | -$75.6K | 0.21% | 68 |
|
|
2017
Q3 | $935K | Sell |
6,689
-5,951
| -47% | -$832K | 0.28% | 55 |
|
|
2017
Q2 | $1.58M | Buy |
+12,640
| New | +$1.58M | 0.5% | 33 |
|
|
2017
Q1 | – | Sell |
-160
| Closed | -$20K | – | 536 |
|
|
2016
Q4 | $20K | Buy |
+160
| New | +$20K | 0.01% | 278 |
|
|
2016
Q2 | – | Sell |
-452
| Closed | -$63K | – | 492 |
|
|
2016
Q1 | $63K | Buy |
+452
| New | +$63K | 0.03% | 159 |
|